Wan S, Zhou X, Xie F, Zhou F, Zhang L
Sci China Life Sci. 2025; .
PMID: 39821829
DOI: 10.1007/s11427-023-2637-2.
Zhao J, Hu S, Qi Z, Xu X, Long X, Huang A
J Immunother Cancer. 2024; 12(12.
PMID: 39631851
PMC: 11624815.
DOI: 10.1136/jitc-2024-009768.
Justus C, Marie M, Sanderlin E, Yang L
Genes (Basel). 2024; 15(9).
PMID: 39336742
PMC: 11431078.
DOI: 10.3390/genes15091151.
Sakellakis M, Reet J, Kladas M, Hoge G, Chalkias A, Radulovic M
Oncol Rev. 2024; 18:1439415.
PMID: 39156014
PMC: 11327047.
DOI: 10.3389/or.2024.1439415.
Xu L, Liu J, An Y, Zhou L, Sun H, Xu Z
BMC Cancer. 2024; 24(1):979.
PMID: 39118022
PMC: 11313097.
DOI: 10.1186/s12885-024-12747-z.
Identification of a metabolism-linked genomic signature for prognosis and immunotherapeutic efficiency in metastatic skin cutaneous melanoma.
He Z, Lyu J, Lyu L, Long X, Xu B
Medicine (Baltimore). 2024; 103(23):e38347.
PMID: 38847706
PMC: 11155616.
DOI: 10.1097/MD.0000000000038347.
Angiogenesis Still Plays a Crucial Role in Human Melanoma Progression.
Cazzato G, Ingravallo G, Ribatti D
Cancers (Basel). 2024; 16(10).
PMID: 38791873
PMC: 11120419.
DOI: 10.3390/cancers16101794.
Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder Cancer.
Alhozeel B, Pandey S, Shteinfer-Kuzmine A, Santhanam M, Shoshan-Barmatz V
Cells. 2024; 13(7.
PMID: 38607066
PMC: 11012128.
DOI: 10.3390/cells13070627.
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer.
Liao M, Yao D, Wu L, Luo C, Wang Z, Zhang J
Acta Pharm Sin B. 2024; 14(3):953-1008.
PMID: 38487001
PMC: 10935242.
DOI: 10.1016/j.apsb.2023.12.003.
Integrative analysis of metabolism subtypes and identification of prognostic metabolism-related genes for glioblastoma.
Li J, Wei Y, Liu J, Cheng S, Zhang X, Qiu H
Biosci Rep. 2024; 44(3).
PMID: 38419527
PMC: 10965397.
DOI: 10.1042/BSR20231400.
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches.
Aryal S, Park S, Park H, Park C, Kim W, Thakur D
Int J Nanomedicine. 2023; 18:7865-7888.
PMID: 38146467
PMC: 10749572.
DOI: 10.2147/IJN.S432839.
Genome-scale modeling predicts metabolic differences between macrophage subtypes in colorectal cancer.
Gelbach P, Finley S
iScience. 2023; 26(9):107569.
PMID: 37664588
PMC: 10474475.
DOI: 10.1016/j.isci.2023.107569.
Amorphous Calcium Carbonate Shows Anti-Cancer Properties That are Attributed to Its Buffering Capacity.
Natan Y, Blum Y, Arav A, Poliansky Y, Neuman S, Ecker Cohen O
Cancers (Basel). 2023; 15(15).
PMID: 37568601
PMC: 10417113.
DOI: 10.3390/cancers15153785.
A novel prognostic signature for hepatocellular carcinoma based on SUMOylation-related genes.
Wang J, Cong P, Jin Z, Liu L, Sun D, Zhu W
Sci Rep. 2023; 13(1):11233.
PMID: 37433803
PMC: 10336129.
DOI: 10.1038/s41598-023-38197-4.
Ensemble-based genome-scale modeling predicts metabolic differences between macrophage subtypes in colorectal cancer.
Gelbach P, Finley S
bioRxiv. 2023; .
PMID: 36993493
PMC: 10052244.
DOI: 10.1101/2023.03.09.532000.
Mitochondrial respiration inhibitor enhances the anti-tumor effect of high-dose ascorbic acid in castration-resistant prostate cancer.
Qiu J, Yang T, Long Y, He P, Shen W, Zhang B
J Mol Med (Berl). 2022; 101(1-2):125-138.
PMID: 36478125
DOI: 10.1007/s00109-022-02273-5.
Research progress on the therapeutic effect and mechanism of metformin for lung cancer (Review).
Han P, Zhou J, Xiang J, Liu Q, Sun K
Oncol Rep. 2022; 49(1).
PMID: 36367180
PMC: 9685221.
DOI: 10.3892/or.2022.8440.
Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality.
Yu L, Zhang J, Li Y
Front Immunol. 2022; 13:871076.
PMID: 36311748
PMC: 9608329.
DOI: 10.3389/fimmu.2022.871076.
Origin, activation, and targeted therapy of glioma-associated macrophages.
Xu C, Xiao M, Li X, Xin L, Song J, Zhan Q
Front Immunol. 2022; 13:974996.
PMID: 36275720
PMC: 9582955.
DOI: 10.3389/fimmu.2022.974996.
A lipid metabolism-related risk signature for patients with gliomas constructed with TCGA and CGGA data.
Meng D, Liu T
Medicine (Baltimore). 2022; 101(36):e30501.
PMID: 36086728
PMC: 9937104.
DOI: 10.1097/MD.0000000000030501.